Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]- d -glucose tracer in mice
Gespeichert in:
Verfasser / Beitragende:
[Richard Beger, Deborah Hansen, Laura Schnackenberg, Brandie Cross, Javad Fatollahi, F. Lagunero, Zoltan Sarnyai, Laszlo Boros]
Ort, Verlag, Jahr:
2009
Enthalten in:
Metabolomics, 5/3(2009-09-01), 336-345
Format:
Artikel (online)
Online Zugang: